Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
  • 首页
The 9th Asia Pharma R&D Leaders

The 9th Asia Pharma R&D Leaders


Time: Jan. 21th-22nd, 2019

Address: Beijing, China


Asia Pharma R&D Leaders 2018 is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. Leading executives will discuss key topics of global R&D trends, development strategies, innovation capability building and collaboration opportunities. It is an efficient exchange platform for global pharmaceutical leaders to optimize R&D strategic innovation, grasp cutting-edge R&D trend, intensify scientific R&D process management and deepen openness to external cooperation; to enhance the Asian pharmaceutical R&D innovation; to go for first in class in the world!

Conference Overview

【Event Background】


Asia Pharma R&D Leaders 2018 is designed to be a premium strategic platform for big pharmas, biotechs, academia and other stake holders in pharma industry to meet, communicate and establish partnership on pharma R&D. Leading executives will discuss key topics of global R&D trends, development strategies, innovation capability building and collaboration opportunities. It is an efficient exchange platform for global pharmaceutical leaders to optimize R&D strategic innovation, grasp cutting-edge R&D trend, intensify scientific R&D process management and deepen openness to external cooperation; to enhance the Asian pharmaceutical R&D innovation; to go for first in class in the world!


By keynote speech, roundtable discussion, company showcase, exhibition booth and 1-2-1 meeting system, this two-day event will share insightful ideas from Asian pharmaceutical leaders, as well as provide fat chances for you to find potential projects and partners. 


》Gather together Asian Pharma R&D leaders, focus on the Latest R&D Hot Spots 

》Hit global forefront biological technology progress, explore a Go-Global R&D strategy

》Analyze the latest pharmaceutical evaluation, examination policies and regulations, understand China Biotechnology R&D Environment

》Innovate External R&D Cooperation Mode, optimize the Whole Life-Cycle R&D Strategy

》Shape scientific Clinical Development Plan, improve R&D Quality and Risk Management

》Study successful Cross-Border Cooperation Cases, collaborate for an Efficient R&D  Process

》Watch the IPO of Innovative Startups, reveal the Challenges and Opportunities


【Your Chances to Meet Part of Previous Attending Companies】


The 9th Asia Pharma R&D Leaders


【A Glance of Past Inspirational Speakers】


The 9th Asia Pharma R&D Leaders

The 9th Asia Pharma R&D Leaders


【Event Highlights】


The 9th Asia Pharma R&D Leaders

Event Organizer

The 9th Asia Pharma R&D Leaders

The 9th Asia Pharma R&D Leaders
Conference Organizer / Co-Organizer

The 9th Asia Pharma R&D Leaders

Guidance / co-sponsor / support
<
  • The New Drug Founders Club
  • PACRA
  • Taiwan Bio
  • Sino-American Pharmaceutical Professionals Association (SAPA)
  • The Chinese Biopharmaceutical Association-USA (CBA)
>
Speakers
  • John Niu co-founder BlueRock Venture Partners
  • Jasmine Cui co-founder Beijing InnoCare Pharma Tech. Ltd.
  • Hongtao Lu co-founder and Chief Scientific Officer Elpiscience Biopharma
  • Ye Hua Chairman & CEO BioNova Pharmaceuticals Ltd
  • Scott Liu President and CEO President and CEO of Shanghai Henlius Biotech Inc.
  • Richard Wang CEO Fosun Kite Biotechnology Co. Ltd
  • Xiang S Ye Executive director Lilly Oncology Discovery China/Asia
  • Qunsheng Ji VP, Head of Oncology & Immunology Unit WuXi AppTec
  • Joan Shen Head of Research and Development I-Mab Biopharma Co., Ltd
  • Yong-jiang Hei CMO Zai Lab
  • Mingde Xia Senior Director Johnson & Johnson Innovation Center AP
  • Lynn Yang
  • Dr. Dan Zhang Executive Chairman Fountain Medical Development Ltd
  • Yuan-Hua Ding Executive Director and Head of External Science Pfizer Worldwide R&D
  • Chengbin WU Founder & CEO EpimAb Biotherapeutics Inc.
  • Binhui (Ben) Ni Operating Partner Pivotal Bioventure Partners
  • Li CHEN Founder and CEO,CSO Hua Medicine (Shanghai) Ltd.
  • Henri Doods VP and Head of Global Research Beyond Borders Boehringer Ingelheim
  • Will LIU Partner Eight Roads Ventures
  • Hong WEN CSO Livzon Pharmaceutical Group Inc.
  • Jian PENG SVP,Regulatory Affairs and Drug Development Strat Beijing Shenogen Pharma Group Ltd.
  • LI Gongshu Senior Vice President Great China Fountain Medical Development LTD
  • Peter LUO Founder and CEO Adagene Inc.
  • Yao-chang XU Founder & CEO Abbisko Therapeutics Co., Ltd.
  • Jun BAO President & CEO IMPACT Therapeutics, Inc.
  • Winnie HAN Senior Vice President Hong Kong Exchanges and Clearing Limited
  • Junyuan WANG Founder, President & CEO AnHeart Therapeutics Inc.
  • Michelle XIA Chairman, President & CEO Akeso Biopharma
  • John ZHU Partner 6 Dimensions Capital
  • Bin SHI Chief Strategy Officer Deuracor Therapeutics, Inc.
  • Tom DU Chief Consultant and Partner Humphries Pharmaceutical Consulting Inc.
  • Fenlai TAN Chairman Lupeng Pharmaceuticals
  • Michael WANG VP China BD and Alliance Management Brii Biosciences
  • Zengjiang CHENG Secretary General / President Tongxieyi New Drug Elite Club / PharmaSea (Be...
  • Wenge ZHONG Co-Founder, Chief Technology Officer Qilu Regor Therapeutics
  • Jie HOU Director of Phase I Clinical Trial Center PKUCare Luzhong Hospital
  • Shun LUO Founder and CEO Jianshun Biosciences Co.,Ltd
  • Jason YANG Chief Medical Officer and Senior VP CStone Pharmaceuticals
Sponsor

The 9th Asia Pharma R&D Leaders

  • Almac
  • Hengdu Law Firm
  • ArisGlobal
  • Beijing Biocytogen Co.,Ltd.
  • Sundia
  • Yaohai Bio
  • Tigermed
  • Etta Biotech Co., Ltd
  • Shanghai Yongzheng Medical Science and Technology Co., Ltd.
  • Zuellig Pharma
Cooperative Media
    APBN
    发布时间: 2018 - 11 - 20
    APBN
    echinaChem
    发布时间: 2018 - 11 - 20
    eChinaChem is the leading integrated B2B company for China chemical, pharmaceutical, and life science industries. eChinaChem operates B2B online marketplace platform in product-level micro-portals; publish product portal magazines; and organizes conferences and events for Chinese and global executives, and provide China consulting and investment advisory services. eChinaChem media reaches 230,000 Chinese industry professionals and decision makers including raw material suppliers, manufacturers, buyers, instrument and equipment makers, service providers, researchers, university professors and their graduate students. eChinaChem is the exclusive China representative for Chemical & Engineering News (C&EN) and American Chemical Society (ACS) publications, and also represent in China ot...
    Lingmed
    发布时间: 2018 - 11 - 20
    Lingmed
    Chinese Journal of Biologicals
    发布时间: 2018 - 11 - 20
    Chinese Journal of Biologicals, hereinafter referred to as Journal, is under the leadership of Ministry of Health of the People's Republic of China and sponsored by China Preventive Medicine Association. It mainly reports information of China biologicals, important R&D achievements and latest progresses of biologicals,as well as the status of worldwide biological and biotechnology products. The main readers of it are production, research and management personnel who come from biological and biotechnology products enterprises, clinician, and government officials who take charge of verification, disease surveillance and control.Biologicals, which are used for the prevention, treatment and diagnose of human disease, are produced of microorganism, cell and animal or human tissue and b...
    药渡网
    发布时间: 2018 - 11 - 20
    药渡网
    贝壳社
    发布时间: 2018 - 11 - 20
    贝壳社
    医谷
    发布时间: 2018 - 11 - 20
    医谷
    Insight-China Pharma Data
    发布时间: 2018 - 11 - 20
    Insight-China Pharma Data, presented by DXY elite team, focusing on collect and analyse medical information and digging insight from vast data.We already have more than 80 thounsands corporate and individual customers, including pharma company, CRO, financial institutions, helping them with product registration, progress, results, patent, bidding, government regulation, industry news and professional consulting service.
    答魔
    发布时间: 2018 - 12 - 21
    http://data.damor.cn/
    CPhI
    发布时间: 2018 - 12 - 21
    Rolled out in 2010, CPhI.CN (www.en-cphi.cn ) is one of the most active vertical B2B online trade platform serving the pharmaceutical industry. As a trusted and reliable source of information, CPhI.cn boasts five sections covering products, suppliers, CAS Database, Events and News, generating unlimited business opportunities for the best suppliers and buyers from whole industry chain, and delivering business news and information for industry professionals every day. Whether your goals is product promotion, brand awareness, lead generation or industry news, CPhI.cn enables your branding and product messages to be delivered into the right hands, and ensures that up-to-date industry information reach you on time.
Agenda
    • The Agenda of The 9th Asia Pharma R&D Leaders

      Day One, Jan 21st, 2019

      Session 1 Drug R&D Strategy

      The Globalization of Local Pharmaceutical Companies under New Regulatory Policy

      Global R&D Pattern: Multinational Pharmaceutical Companies' R&D Strategy Innovation

      Session 2 Drug Regulatory Policy

      The Global New Drug Development under China Pharmaceutical Regulatory Reform

      Session 3 Drug R&D Trend

      Trend and Opportunity: Immuno-Oncology Drug Combination Research and Development

      Day Two, Jan 22nd, 2019

      Session 4 Clinical Development Strategy

      Clinical R&D Strategy for Global Synchronous Development

      The Comprehensive Considerations of Pre-Clinical and Clinical Development

      Session 5 Road to Entrepreneurship

      Keynote Presentation: Choice and Considerations: the Biotech’s Way of Listing

      Opportunities and Challenges: the Journey of New Drug Entrepreneurs

      Session 6 External Innovation Opportunity

      The Strategy Innovation of External Research Collaboration

      Session 7 Collaboration with Investors

      The Investors’ Perspective: Future Biomedical Investment Trend and Value Evaluation

Travel & Stay

The 9th Asia Pharma R&D Leaders